CIA
TECH icon

CSat Investment Advisory’s Bio-Techne TECH Stock Holding History

CSat Investment Advisory’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-636
Closed -$39K – 915
2020
Q3 		$39K Buy
636
+72
+13% +$4.68K ﹤0.01% 705
2020
Q2 		$37K Buy
564
+88
+18% +$5.27K ﹤0.01% 718
2020
Q1 		$23K Buy
476
+84
+21% +$4.2K ﹤0.01% 702
2019
Q4 		$22K Buy
392
+48
+14% +$2.52K 0.01% 762
2019
Q3 		$17K Buy
344
+48
+16% +$2.41K 0.01% 758
2019
Q2 		$15K Buy
+296
New +$14.9K 0.01% 763

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CSat Investment Advisory's TECH Position: Q4 2020 in Review

CSat Investment Advisory sold out of Bio-Techne (TECH) in Q4 2020, closing a stake of 636 shares — an estimated $39K sold.

CSat Investment Advisory first reported a position in TECH in Q2 2019 and held it in 6 quarters. The position peaked at $39K in Q3 2020. 441 funds tracked by Wall St. Rank hold TECH as of Q4 2020.

  • CSat Investment Advisory reported no remaining Bio-Techne position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 636 Bio-Techne shares in Q4 2020, an estimated $39K.
  • CSat Investment Advisory first reported a position in Bio-Techne in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's Bio-Techne position peaked at $39K in Q3 2020.
  • 441 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.